Jordane Demonchy
Overview
Explore the profile of Jordane Demonchy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demonchy J, Biard L, Clere-Jehl R, Wallet F, Mokart D, Moreau A, et al.
Emerg Infect Dis
. 2024 Jan;
30(2).
PMID: 38270146
Invasive fusariosis can be life-threatening, especially in immunocompromised patients who require intensive care unit (ICU) admission. We conducted a multicenter retrospective study to describe clinical and biologic characteristics, patient outcomes,...
2.
Arnaud M, Demonchy J, Arrii E, Luperto M, Lion J, Fodil S, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35562918
Histones are widely recognized as pro-inflammatory mediators upon their release from the nucleus into the extracellular space. However, their impact on endothelial cell immunogenicity is unknown. Endothelial cells, Human Microvascular...
3.
Arnaud M, Loiselle M, Vaganay C, Pons S, Letavernier E, Demonchy J, et al.
J Am Soc Nephrol
. 2022 May;
33(6):1154-1171.
PMID: 35523579
Background: The pathophysiology of AKI during tumor lysis syndrome (TLS) is not well understood due to the paucity of data. We aimed to decipher crystal-dependent and crystal-independent mechanisms of TLS-induced...
4.
Demonchy J, Cordier C, Frealle E, Demarquette H, Herbaux C, Escure G, et al.
Clin Lymphoma Myeloma Leuk
. 2021 Mar;
21(6):e545-e547.
PMID: 33642203
No abstract available.
5.
Duployez N, Demonchy J, Berthon C, Goutay J, Caplan M, Moreau A, et al.
Cancers (Basel)
. 2020 Jul;
12(7).
PMID: 32708264
Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring hospitalization and intensive care. In recent years, clonal hematopoiesis (CH) of...
6.
Jovanovic K, Escure G, Demonchy J, Willaume A, Van de Wyngaert Z, Farhat M, et al.
Front Oncol
. 2019 Jan;
8:665.
PMID: 30687640
Multiple Myeloma (MM) is an incurable disease characterized by a clonal evolution across the course of the diseases and multiple lines of treatment. Among genomic drivers of the disease, alterations...